H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 127 Citations 56,793 874 World Ranking 1166 National Ranking 23

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

His primary areas of study are Transplantation, Internal medicine, Surgery, Immunology and Hematopoietic stem cell transplantation. Gérard Socié has included themes like Aplastic anemia, Cyclophosphamide, Anemia, Histocompatibility and Acute leukemia in his Transplantation study. His research in Internal medicine intersects with topics in Gastroenterology and Oncology.

His Surgery research includes themes of Incidence, Cumulative incidence and Hazard ratio. He regularly links together related areas like Stem cell in his Immunology studies. His research integrates issues of Cancer, Hematopoietic cell, Transplantation Conditioning, Fludarabine and Cohort in his study of Hematopoietic stem cell transplantation.

His most cited work include:

  • Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia (959 citations)
  • The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (845 citations)
  • Solid Cancers after Bone Marrow Transplantation (763 citations)

What are the main themes of his work throughout his whole career to date?

Gérard Socié spends much of his time researching Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Surgery and Immunology. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology. His studies in Gastroenterology integrate themes in fields like Cyclophosphamide and Eculizumab.

He usually deals with Transplantation and limits it to topics linked to Stem cell and Hematology. In his study, which falls under the umbrella issue of Hematopoietic stem cell transplantation, Busulfan is strongly linked to Regimen. The various areas that he examines in his Surgery study include Aplastic anemia and Cohort.

He most often published in these fields:

  • Internal medicine (71.71%)
  • Transplantation (64.64%)
  • Hematopoietic stem cell transplantation (46.27%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (71.71%)
  • Transplantation (64.64%)
  • Oncology (23.08%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Graft-versus-host disease. His research in Internal medicine tackles topics such as Gastroenterology which are related to areas like Cumulative incidence. Within one scientific family, he focuses on topics pertaining to Stem cell under Transplantation, and may sometimes address concerns connected to Cancer research.

In his research, Confidence interval is intimately related to Cohort, which falls under the overarching field of Oncology. His work carried out in the field of Hematopoietic stem cell transplantation brings together such families of science as Hematology, Human leukocyte antigen and Myelofibrosis. The Graft-versus-host disease study combines topics in areas such as Immunology, Bone marrow, Anti-thymocyte globulin and Calcineurin.

Between 2017 and 2021, his most popular works were:

  • Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (99 citations)
  • A landscape of germ line mutations in a cohort of inherited bone marrow failure patients (98 citations)
  • A landscape of germ line mutations in a cohort of inherited bone marrow failure patients (98 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

His main research concerns Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Gastroenterology. His Transplantation research is multidisciplinary, incorporating elements of Total body irradiation, Cyclophosphamide and Cohort. His Oncology study incorporates themes from Cancer, Haematopoiesis, Stem cell and Risk factor.

His Hematopoietic stem cell transplantation study combines topics in areas such as Myelofibrosis and Metabolomics. His Gastroenterology research integrates issues from Aplastic anemia, Immunosuppression, Tacrolimus, Cumulative incidence and Proportional hazards model. His Graft-versus-host disease research incorporates elements of Calcineurin, Immune system, Immunology, Bone marrow and Receptor.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

Marina Cavazzana-Calvo;Emmanuel Payen;Olivier Negre;Gary Wang.
Nature (2010)

1326 Citations

The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen;Neal S. Young;Jörg Schubert;Robert A. Brodsky.
The New England Journal of Medicine (2006)

1148 Citations

Solid Cancers after Bone Marrow Transplantation

Rochelle E. Curtis;Philip A. Rowlings;H. Joachim Deeg;Donna A. Shriner.
The New England Journal of Medicine (1997)

982 Citations

Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Charles Parker;Mitsuhiro Omine;Stephen Richards;Jun-Ichi Nishimura.
Blood (2005)

922 Citations

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

Rochelle E. Curtis;Lois B. Travis;Philip A. Rowlings;Gérard Socié.
Blood (1999)

741 Citations

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Jürgen Finke;Wolfgang A Bethge;Claudia Schmoor;Hellmut D Ottinger.
Lancet Oncology (2009)

720 Citations

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors

Gérard Socié;Jean-Yves Mary;Aimery de Gramont;Bernard Rio.
The Lancet (1996)

619 Citations

Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.

Peter Hillmen;Petra Muus;Ulrich Dührsen;Antonio M. Risitano.
Blood (2007)

581 Citations

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse

Stephanie J. Lee;John P. Klein;A. John Barrett;Olle Ringden.
Blood (2002)

569 Citations

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation

Navneet S. Majhail;Navneet S. Majhail;J. Douglas Rizzo;Stephanie J. Lee;Mahmoud Aljurf.
Biology of Blood and Marrow Transplantation (2012)

568 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Gérard Socié

Mohamad Mohty

Mohamad Mohty

Université Paris Cité

Publications: 235

Bipin N. Savani

Bipin N. Savani

Vanderbilt University Medical Center

Publications: 202

Xiao-Jun Huang

Xiao-Jun Huang

Peking University

Publications: 202

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 198

Stephanie J. Lee

Stephanie J. Lee

Fred Hutchinson Cancer Research Center

Publications: 184

Daniel J. Weisdorf

Daniel J. Weisdorf

University of Minnesota

Publications: 184

Myriam Labopin

Myriam Labopin

Université Paris Cité

Publications: 163

Paul J. Martin

Paul J. Martin

Fred Hutchinson Cancer Research Center

Publications: 153

Joseph H. Antin

Joseph H. Antin

Harvard University

Publications: 133

Corey Cutler

Corey Cutler

Harvard University

Publications: 133

Jakob Passweg

Jakob Passweg

University Hospital of Basel

Publications: 132

Hillard M. Lazarus

Hillard M. Lazarus

Case Western Reserve University

Publications: 126

Bruce R. Blazar

Bruce R. Blazar

University of Minnesota

Publications: 126

Nicolaus Kröger

Nicolaus Kröger

Universität Hamburg

Publications: 122

Franco Locatelli

Franco Locatelli

Bambino Gesù Children's Hospital

Publications: 112

Sergio Giralt

Sergio Giralt

Memorial Sloan Kettering Cancer Center

Publications: 108

Something went wrong. Please try again later.